Get a glimpse into our company and investor data—powered by the PitchBook Platform
Anthrax vaccine program and related assets and technology. The portfolio includes all assets and rights related to a recombinant protective antigen (rPA) anthrax vaccine product.
This information is reserved for PitchBook Platform users. To explore Vaxgen (Anthrax Vaccine Assets and Technology)‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.